Mehr, S. R. (2016). Will the PCSK9 Inhibitors Be Employers’ “Line in the Sand”? Am Health Drug Benefits.
Citação norma ChicagoMehr, Stanton R. "Will the PCSK9 Inhibitors Be Employers’ “Line in the Sand”?" Am Health Drug Benefits 2016.
Citação norma MLAMehr, Stanton R. "Will the PCSK9 Inhibitors Be Employers’ “Line in the Sand”?" Am Health Drug Benefits 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.